Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PACB
    4. >
  4. Valuation

Valuation

-
stocks logo
PACB
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is PACB Overvalued？

PACB is now in the zone, suggesting that PACB current forward PE ratio of -2.41 is considered compare with the five-year average of 7.17.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

PACB Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
PACB.O
Pacific Biosciences of California Inc
loss
Average P/E: 26.90
15.15%
451.87M
stocks logo
DCTH.O
Delcath Systems Inc
loss
Average P/E: 26.90
105.06%
514.80M
stocks logo
CVRX.O
CVRx Inc
loss
Average P/E: 26.90
-32.72%
457.74M
stocks logo
ORGO.O
Organogenesis Holdings Inc
loss
Average P/E: 26.90
287.83%
442.55M
stocks logo
TCMD.O
Tactile Systems Technology Inc
26.90
Average P/E: 26.90
-77.27%
416.35M
stocks logo
CLPT.O
Clearpoint Neuro Inc
loss
Average P/E: 26.90
7.67%
490.59M

PACB Revenue Breakdown & PS Ratio Relation

By Business
By Region
Currency:USD
Composition ()
Name
Revenue
Percentage

PACB FAQs

Is PACB currently overvalued based on its P/E ratio?

According to the provided data, PACB's 5-year historical average forward P/E ratio is 7.19. PACB forward P/E ratio is -2.41, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for PACB?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has PACB's Price to Sales (PS) ratio evolved?

The PS ratio increased from 1.93 to 2.66, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for PACB's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

PACB PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
7.17
Current PE
-2.41
Overvalued PE
69.17
Undervalued PE
-54.82

PACB EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-13.69
Current EV
-5.05
Overvalued EV
-1.28
Undervalued EV
-26.11

PACB P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
16.36
Current PS
2.64
Overvalued PS
30.42
Undervalued PS
2.31

PACB Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
PACB.O
Pacific Biosciences of California Inc
loss
Average P/E: 26.90
15.15%
451.87M
stocks logo
DCTH.O
Delcath Systems Inc
loss
Average P/E: 26.90
105.06%
514.80M
stocks logo
CVRX.O
CVRx Inc
loss
Average P/E: 26.90
-32.72%
457.74M
stocks logo
ORGO.O
Organogenesis Holdings Inc
loss
Average P/E: 26.90
287.83%
442.55M
stocks logo
TCMD.O
Tactile Systems Technology Inc
26.90
Average P/E: 26.90
-77.27%
416.35M
stocks logo
CLPT.O
Clearpoint Neuro Inc
loss
Average P/E: 26.90
7.67%
490.59M

PACB Revenue Breakdown & PS Ratio Relation

By Business
By Region
Currency:USD
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is PACB undervalued？Is PACB overvalued compared to its competitors？

PACB FAQs

Is PACB currently overvalued based on its P/E ratio?

According to the provided data, PACB's 5-year historical average forward P/E ratio is 7.19. PACB forward P/E ratio is -2.41, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for PACB?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has PACB's Price to Sales (PS) ratio evolved?

The PS ratio increased from 1.93 to 2.66, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for PACB's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is PACB undervalued？Is PACB overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free